01 May 2006
Urinary activities of cathepsin B, N-acetyl-ss-D-glucosaminidase, and albuminuriain patients with type 2 diabetes mellitus.
Agnieszka Piwowar, Maria Knapik-Kordecka, Izabela Fus, Maria WarwasMed Sci Monit 2006; 12(5): CR210-214 :: ID: 450290
Abstract
Background: The proximal kidney tubule contains a large number of lysosomesinvolved in the breakdown of intracellular as well as reabsorbed proteins. When tubular protein reabsorptionis overburdened or when there is tubular cell damage, higher urinary excretion of lysosomal enzymes,e.g. cathepsins and N-acetyl-beta-D-glucosaminidase (NAG), can be found. We compared urinary cathepsinB (CB) activity with NAG in diabetic patients. Material/Methods: Using fluorogenic substrates, urinaryand plasma CB and NAG activities in 130 type 2 diabetic patients with varying stages of albuminuria and42 control subjects were determined. Early morning urine samples were used. Results: In the patients,only higher values of plasma NAG were found. In urine, CB and NAG activities increased progressivelyfrom normoalbuminuria, through microalbuminuria to macroalbuminuria group. The normoalbuminuria grouphad both enzyme activities higher than healthy controls. Urine CB activity in the patients also increasedgradually to tertiles of urinary NAG. Only urinary CB activity was significantly associated with glycemicstate. The correlation was stronger in the patients with poor glycemic control. The plasma/urine ratiosfor both CB and NAG decreased in the patients compared with controls. Conclusions: Determination of urinaryCB activity might be useful as a non-invasive surrogate marker of incipient nephropathy.
Keywords: Acetylglucosaminidase - urine, Aged, 80 and over, Albuminuria - urine, Biological Markers - urine, Case-Control Studies, Cathepsin B - urine, Diabetes Mellitus, Type 2 - urine, Diabetic Nephropathies - urine
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
08 Feb 2024 : Clinical Research
Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparat...Med Sci Monit In Press; DOI: 10.12659/MSM.942882
09 Feb 2024 : Clinical Research
Factors Influencing the Occurrence of Intraoperative Hypothermia in Patients Undergoing General Anesthesia ...Med Sci Monit In Press; DOI: 10.12659/MSM.943463
13 Feb 2024 : Clinical Research
A Retrospective Study to Compare the Glasgow Coma Score, Pediatric Trauma Score, and Injury Severity Score ...Med Sci Monit In Press; DOI: 10.12659/MSM.943501
16 Feb 2024 : Clinical Research
Etiology, Clinical Presentation, and Outcomes of Bacterial Meningitis in Adult Patients: A Retrospective St...Med Sci Monit In Press; DOI: 10.12659/MSM.942904
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952